贝泰妮：云南贝泰妮生物科技集团股份有限公司2025年半年度报告摘要_英文版.PDF

1、Yunnan Botanee Bio-Technology Group Co.,Ltd.Summary of the 2025 Semi-annual Report1Stock code:300957Stock abbreviation:BotaneeAnnouncement number:2025-034Yunnan Botanee Biotechnology Group Co.,Ltd.Summary of 2025 Semi-annual ReportYunnan Botanee Bio-Technology Group Co.,Ltd.Summary of the 2025 Semi-

2、annual Report2I.Important NoticeThis summary of semi-annual report is derived from the full text of the semi-annual report.To fully understand the Companysoperating results,financial status,and future development plans,investors should carefully read the full semi-annual report on themedia designate

3、d by the China Securities Regulatory Commission.All directors attended the Board meeting for deliberating on this report.Notice of the non-standard audit opinionApplicableNot applicableProfit distribution plan or capital reserve transfer plan to increase capital approved by the board during the repo

4、rting periodApplicableNot applicableThe profit distribution plan for preferred shares approved by the Board during the reporting periodApplicableNot applicableII.Company Overview1.Company ProfileStock nameBotaneeStock code300957Stock listing exchangeShenzhen Stock ExchangeContact person and contact

5、informationBoard SecretarySecurities representativeNameWang LongXu MinjingTel.021-6232 1125021-6232 1125Office addressNo.53,Keyi Road,Kunming High-techIndustrial Development Zone,Kunming,Yunnan ProvinceNo.53,Keyi Road,Kunming High-techIndustrial Development Zone,Kunming,Yunnan ProvinceE2.Key Account

6、ing Data and Financial IndicatorsWhether the Company retrospectively adjusted or restated accounting data for previous years YesNoThe reportingperiodSame period ofthe previous yearYoYincrease/decreaseOperating revenue(CNY)2,371,842,584.762,804,672,799.97-15.43%Net profit attributable to our sharehol